<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04257188</url>
  </required_header>
  <id_info>
    <org_study_id>19-169</org_study_id>
    <nct_id>NCT04257188</nct_id>
  </id_info>
  <brief_title>Safety and Feasibility of Sutureless Pars-plana Vitrectomy in Sub-Tenon Anesthesia</brief_title>
  <acronym>SAFE-VISA</acronym>
  <official_title>A Prospective, One-center Clinical Trial to Identify the Safety and Feasibility of Sutureless Pars-plana Vitrectomy Performed in Sub-tenon Anesthesia.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RWTH Aachen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RWTH Aachen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this prospective study is to investigate the feasibility of performing minimally&#xD;
      invasive vitrectomy under sub-tenon anesthesia in terms of intraoperative patients' tolerance&#xD;
      and the surgeon's confidence. In particular, the tolerance and pain sensation during the&#xD;
      operation as well as the possible perception of light and colour sensations are to be&#xD;
      recorded with the help of questionnaires. In addition, the surgeon's impressions regarding&#xD;
      eye motility, chemosis and general feasibility will be evaluated.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective, one-center clinical trial to identify the safety and feasibility of sutureless&#xD;
      pars-plana vitrectomy performed in sub-tenon anesthesia.&#xD;
&#xD;
      Background:&#xD;
&#xD;
      In Germany pars-plana vitrectomies are mostly performed in general anesthesia. This requires&#xD;
      the immediate availability of a trained anesthesiology team, which is not always granted,&#xD;
      especially in urgent eye disease (i.e. endophthalmitis, high risk retinal detachment).&#xD;
      Furthermore, some patients are not suitable for general anesthesia due to systemic diseases&#xD;
      (i.e. cardio-vascular diseases). There are several procedures of local ocular anesthesia&#xD;
      (i.e. peribulbar, retrobulbar, sub-tenon anesthesia). The main advantage of sub-tenon&#xD;
      anesthesia is the use of a blunt cannula limiting the risk of potential complications.&#xD;
&#xD;
      Purpose:&#xD;
&#xD;
      The purpose of this study is to investigate the safety of local sub-tenon anesthesia&#xD;
      procedure for sutureless vitrectomy (anesthetic mixture: 2ml xylocaine and 2ml bupivacaine)&#xD;
      in a prospective clinical study design.&#xD;
&#xD;
      Objectives:&#xD;
&#xD;
      Primary outcome: The evaluation of 1. sensation of pain, 2. patients' intraoperative&#xD;
      discomfort and 3. visual sensations using the standardized questionnaires (WONG-BAKER Faces&#xD;
      Scale, Visual Analog Scale and individual questions).&#xD;
&#xD;
      Secondary Outcome: The evaluation of 1. chemosis, 2. eye movement, 3. surgeon's general&#xD;
      feeling of comfort during surgery (rating scale).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 7, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sensation of pain</measure>
    <time_frame>1 Day</time_frame>
    <description>11-point numeric scale ranges from '0' (means &quot;no pain&quot;) to '10' (means &quot;worst pain imaginable&quot;), Questionnaire&#xD;
Wong-Baker FACESÂ® Scale (6 Faces, range no hurt - hurts worst), Questionnaire</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Discomfort</measure>
    <time_frame>1 Day</time_frame>
    <description>11-point numeric scale ranges from '0' (means &quot;no discomfort&quot;) to '10' (means &quot;worst discomfort imaginable&quot;), Questionnaire</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Sensations</measure>
    <time_frame>1 Day</time_frame>
    <description>4 questions, Likert scale (&quot;yes&quot;, &quot;no&quot;, &quot;don't know/not sure&quot;), Questionnaire&#xD;
perception of details during surgery (instruments, surgeon's face)&#xD;
perception of colors during surgery&#xD;
perception of lights or shadows&#xD;
no light perception at all during surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Chemosis</measure>
    <time_frame>1 Day</time_frame>
    <description>5-point numeric scale from '0' (means no chemosis) to 4 (means chemosis of all 4 eye quadrants), Questionnaire (surgeon)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Eye movement</measure>
    <time_frame>1 Day</time_frame>
    <description>4-point numeric scale: '0' (means ptosis and no motility), '1' (mild motility), '2' (moderate motility), '3' (full motility), Questionnaire (surgeon)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgeon's general feeling of comfort during the surgery</measure>
    <time_frame>1 Day</time_frame>
    <description>6-point numeric scale ranges from '1' (means best comfort conditions) to '6' (means worst comfort conditions) Questionnaire (surgeon)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Vitreoretinal Diseases</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>minimally invasive vitrectomy under subtenon anaesthesia</intervention_name>
    <description>The safety and feasibility in terms of tolerance and pain sensation during the surgery as well as the possible perception of light and colour sensations in minimally invasive vitrectomy under sub-tenon anesthesia shall be investigated.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Study population is acquired from the patient collective of the eye clinic of the&#xD;
        University Hospital Aachen and have a medical indication for vitrectomy, which is&#xD;
        independent of study participation.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age over 40 years&#xD;
&#xD;
          -  Presence of a clinical condition that requires surgical treatment with vitrectomy and&#xD;
             does not necessarily require general anesthesia (retinal detachment, endophthalmitis,&#xD;
             vitreous hemorrhage, after silicone oil surgery, vitreomacular traction, epiretinal&#xD;
             gliosis, macular holes, subretinal bleeding, lens luxation).&#xD;
&#xD;
               -  The medical indication for vitrectomy is not linked to study participation. Not&#xD;
                  until the patient has consented to the vitrectomy (standardized information&#xD;
                  forms) potential study subjects will be approached to participate in the clinical&#xD;
                  trial.&#xD;
&#xD;
          -  Willingness to participate in the clinical trial&#xD;
&#xD;
          -  Understanding the objectives of the clinical trial and the study process&#xD;
&#xD;
          -  Signed informed consent form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Concomitant diseases of the eye&#xD;
&#xD;
               -  State after filtering glaucoma operations&#xD;
&#xD;
               -  Distinct corneal opacities, which make the examination considerably more&#xD;
                  difficult&#xD;
&#xD;
               -  Complicated proliferative vitreoretinopathy&#xD;
&#xD;
          -  Lack of understanding of the study, its objectives and study conduct&#xD;
&#xD;
          -  Psychiatric diseases&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Simultaneous participation in another clinical trial&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonis Koutsonas, Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinic for Ophthalmology, University Hospital RWTH Aachen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tibor Lohmann, Dr. med.</last_name>
    <phone>+49(0) 241 80 88191</phone>
    <email>tlohmann@ukaachen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Antonis Koutsonas, Dr. med.</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clinic for Ophthalmology, University Hospital RWTH Aachen</name>
      <address>
        <city>Aachen</city>
        <zip>52066</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tibor Lohmann, Dr. med.</last_name>
      <email>tlohmann@ukaachen.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>November 19, 2019</study_first_submitted>
  <study_first_submitted_qc>February 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2020</study_first_posted>
  <last_update_submitted>February 4, 2020</last_update_submitted>
  <last_update_submitted_qc>February 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>RWTH Aachen University</investigator_affiliation>
    <investigator_full_name>Antonis Koutsonas</investigator_full_name>
    <investigator_title>Dr. med. Antonis Koutsonas</investigator_title>
  </responsible_party>
  <keyword>Sub-tenon Anesthesia</keyword>
  <keyword>Vitrectomy</keyword>
  <keyword>Sutureless vitrectomy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

